Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Sword & Shield Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 4.60 -0.03  | -0.65% 74.24% - 2.37
BSE Price: Dec 10, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 10, 2019 4.60 -0.03 -0.65% 4.59 4.63 100 4.59 - 4.63
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 3,350 P/B: 50.27 NSE Code:
52-Week Range: R 2.36 - 7.45 Dividend Yield: 0.00% BSE Code: 531637
TTM EPS: R -0.17 Book Value: R 0.09 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 37 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Sword & Shield Pharma - -10.51 - 73.46 - - -
S&P BSE Small Cap -10.62 -2.45 3.42 -5.06 2.18 3.05 5.05
S&P BSE Healthcare -5.05 1.00 1.56 -1.67 -5.25 -2.33 10.29
Company's return has been calculated on basis of BSE's price.
As on Dec 10, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -33.18 697.79 -48.86
Net Profit 47.64 -171.68 13.96
EPS 47.64 -169.33 14.05
Book Value -43.99 -3.69 -3.59
Average
Operating Margin -433.66 -421.54 199,149.72
Net Margin -353.15 -389.80 -232.23
Return on Networth -56.39 -215.59 -129.35
Return on Investment -56.23 -74.84 -48.28
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - 360.00 187.50
Operating Profit 96.55 84.62 87.50
Net Profit 96.55 84.62 87.50
EPS 96.54 84.52 87.46
TTM
Revenue 90.00 280.00 90.00
Operating Profit 11.46 35.61 -3.66
Net Profit 11.46 35.61 -3.66
EPS 11.43 35.56 -3.71
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Sword & Shield Pharma 2.37 0.04 -0.09 -202.38 -56.39 50.27 -
Astrazeneca Pharma India 6,683.13 818.54 74.85 8.97 20.03 20.28 89.29
Procter & Gamble Health 6,936.55 894.23 835.89 14.21 73.79 8.90 51.75
News & Announcements
Contact Information

Company: Sword & Shield Pharma Ltd.

Address: 55, World Business House, Near Parimal Garden, Ambawadi, Ahmedabad, Gujarat - 380006 | Phone: +91 98250 79759

Email: [email protected]

Website: www.swordnshieldpharma.com

Registrar & Transfer Agent: MCS Ltd

Address: 101 Shatdal Complex , 1st Floor,Opp. Bata Show Room,Ashram Road,Ahmedabad, 101 Shatdal Complex , 1st Floor, Opp. Bata Show Room, Ashram Road | Phone: 079-6582878 | Fax: 079-6584027

Email: [email protected]

Essential checks
Altman Z-Score
69.73
Piotroski F-Score
5
Modified C-Score
5
1-Year Price to Earnings
Not available
1-Year Price to Book
50.27
Earnings Yield
EBIT / Enterprise value
-3.61%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,671.15 -3.38%
Eris Lifesciences R475.80 -2.68%
FDC R206.95 -0.31%
Granules India R124.90 +2.08%
JB Chemicals & Pharma R422.35 +5.14%
Laurus Labs R334.60 -0.22%
Procter & Gamble Health R4,181.40 -1.94%
Strides Pharma Science R371.25 -0.50%
Sun Pharma Adv. Research R170.05 +4.65%
Suven Life Sciences R265.25 -1.92%
As on Dec 10, 15:59